GMNN and gastric cancer: Knockdown of LPAR3 reduced the protein level of geminin that was increased by LPA treatment (Figures 6D,F), whereas no change in geminin expression was observed in gastric cancer cells that were transfected with a control siRNA (sitrl) or siLPAR3 in the absence of LPA (Figure 6C).